'[This] is stigmatizing and ethically troubling': Guidance for clinicians when health status shapes immigration decisions

As of November 2025, US visa officers have been directed, under the “public charge” rule, to evaluate applicants’ chronic health conditions, including obesity, diabetes, cardiovascular and respiratory diseases, cancer, and mental health conditions.^[] The directive introduces a new layer of scrutiny concerning chronic disease and places greater weight on physician documentation.

Shift in medical criteria for visa screening

Historically, immigration medical evaluations focused on communicable diseases and vaccination status.^[] The new guidelines expand this focus to a broad set of chronic conditions that may require long-term care or generate cumulative healthcare costs.^[]

This shift has prompted concern among clinicians.

Psychiatrist Barbara Sparacino, MD, tells MDLinx that common chronic illness is being recast as a rationale for exclusion: “This directive takes conditions that are common, chronic, and often very treatable … and turns them into potential grounds for exclusion … That is stigmatizing, medically simplistic, and ethically troubling.” She adds, “It also ignores the reality that chronic illness is the norm, not the exception, in aging populations and in many communities worldwide. For example, about 40% of US adults meet criteria for obesity, and a substantial proportion live with at least one chronic condition. To treat these very common health issues as red flags for immigration decisions risks turning health status into a proxy for socioeconomic or racial exclusion.”

What clinicians should keep in mind

1. Documentation of disease control and prognosis

For patients undergoing visa review, clinicians should expect closer attention to indicators of stability: HbA1c, blood pressure, BMI trends, and absence of complications.

Brian Clark, BSN, MSNA, a nurse anesthetist and the founder of United Medical Education, emphasizes how measurable control is often ignored in immigration settings: “The A1c levels and heart failure biomarkers of many of these patients remained low … However, during the process of going through an international border crossing, they were viewed as having a high-risk medical status … Visa processes should incorporate objective measures rather than blanket exclusions.”

2. Comorbidity patterns and perceived cumulative risk

The directive emphasizes obesity because of its association with hypertension, sleep apnea, asthma, and other conditions.^[] Patients with multiple diagnoses may be perceived as higher risk, even when their conditions are stable.

3. Financial and insurance context

The directive instructs officers to assess whether “the applicant [has] adequate financial resources to cover the costs of such care over his entire expected lifespan without seeking public cash assistance or long-term institutionalization at government expense.”^[]

4. Dependents and special-needs considerations

The guidelines also direct officers to assess how much an applicant’s medical conditions might cost the US. The November cable asks, “Does the applicant have adequate financial resources to cover the costs of such care over his entire expected lifespan without seeking public cash assistance or long-term institutionalization at government expense?”

Clinically, this may require documenting functional status rather than listing diagnoses alone.

Ethical tensions

The directive raises concerns about stigma, disclosure, and trust.

Dr. Smith (*name changed for anonymity), an endocrinologist, adds, “If clinicians are involved with making determinations of an applicant’s health, it may result in conflicts of interest.”

Qiao YuFei, MD, a family physician and the CEO of Mediway Medical Centre in Singapore, says, “I worry that this policy will dissuade patients from coming for care, break the trust between them and us during consultations, and encourage dishonesty with health facts for fear of potential instability of the family.”